2-[[2-(4-bromo-N-methylsulfonylanilino)acetyl]-[(2-methylphenyl)methyl]amino]-N-cyclopentylpropanamide
C25H32BrN3O4S — CID 132627044
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-(4-bromo-N-methylsulfonylanilino)acetyl]-[(2-methylphenyl)methyl]amino]-N-cyclopentylpropanamide
2-[[2-(4-bromo-N-methylsulfonylanilino)acetyl]-[(2-methylphenyl)methyl]amino]-N-cyclopentylpropanamide (PubChem CID 132627044) has the molecular formula C25H32BrN3O4S and a molecular weight of 550.52 g/mol. Its IUPAC name is 2-[[2-(4-bromo-N-methylsulfonylanilino)acetyl]-[(2-methylphenyl)methyl]amino]-N-cyclopentylpropanamide.
Molecular Properties
| Compound Name | 2-[[2-(4-bromo-N-methylsulfonylanilino)acetyl]-[(2-methylphenyl)methyl]amino]-N-cyclopentylpropanamide |
|---|---|
| PubChem CID | 132627044 |
| Molecular Formula | C25H32BrN3O4S |
| Molecular Weight | 550.52 g/mol |
| Exact Mass | 549.13 |
| IUPAC Name | 2-[[2-(4-bromo-N-methylsulfonylanilino)acetyl]-[(2-methylphenyl)methyl]amino]-N-cyclopentylpropanamide |
| SMILES | Cc1ccccc1CN(C(=O)CN(c1ccc(Br)cc1)S(C)(=O)=O)C(C)C(=O)NC1CCCC1 |
| InChI | InChI=1S/C25H32BrN3O4S/c1-18-8-4-5-9-20(18)16-28(19(2)25(31)27-22-10-6-7-11-22)24(30)17-29(34(3,32)33)23-14-12-21(26)13-15-23/h4-5,8-9,12-15,19,22H,6-7,10-11,16-17H2,1-3H3,(H,27,31) |
| InChIKey | FTZPCYFMMYMOCG-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 86.79 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 550.52 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 132627044 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.